The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Open accessAbstract
Cancer cells adapt their metabolic processes to drive macromolecular biosynthesis for rapid cell growth and proliferation. RNA interference (RNAi)-based loss-of-function screening has proven powerful for the identification of new and interesting cancer targets, and recent studies have used this technology in vivo to identify novel tumour suppressor genes. Here we developed a method for identifying novel cancer targets via negative-selection RNAi screening using a human breast cancer xenograft model at an orthotopic site in the mouse. Using this method, we screened a set of metabolic genes associated with aggressive breast cancer and stemness to identify those required for in vivo tumorigenesis. Among the genes identified, phosphoglycerate dehydrogenase (PHGDH) is in a genomic region of recurrent copy number gain in breast cancer and PHGDH protein levels are elevated in 70% of oestrogen receptor (ER)-negative breast cancers. PHGDH catalyses the first step in the serine biosynthesis pathway, and breast cancer cells with high PHGDH expression have increased serine synthesis flux. Suppression of PHGDH in cell lines with elevated PHGDH expression, but not in those without, causes a strong decrease in cell proliferation and a reduction in serine synthesis. We find that PHGDH suppression does not affect intracellular serine levels, but causes a drop in the levels of α-ketoglutarate, another output of the pathway and a tricarboxylic acid (TCA) cycle intermediate. In cells with high PHGDH expression, the serine synthesis pathway contributes approximately 50% of the total anaplerotic flux of glutamine into the TCA cycle. These results reveal that certain breast cancers are dependent upon increased serine pathway flux caused by PHGDH overexpression and demonstrate the utility of in vivo negative-selection RNAi screens for finding potential anticancer targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Functional PHGDH loss is toxic to tumor cells with PHGDH amplification or high serine biosynthetic flux (Locasale et al., 2011; Mattaini et al., 2015; Possemato et al., 2011; Zhang et al., 2017), and small-molecule inhibitors targeting PHGDH have been shown to inhibit serine synthesis and tumor proliferation in vitro and in xenograft cancer models (Mullarky et al., 2016; Pacold et al., 2016; Wang”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“Serine is present in plasma and can be taken up by cells via amino acid transporters, yet PHGDH expression and increased serine biosynthesis have been shown to be important for supporting cancer cell proliferation and survival in both in vitro and in vivo settings (Locasale et al., 2011; Possemato et al., 2011).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“Increased PHGDH gene expression leads to greater production of serine from glucose and is associated with specific subsets of breast cancer, lung adenocarcinoma, and melanoma (Locasale et al., 2011; Possemato et al., 2011; Zhang et al., 2017).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“More recently, it was found that increased expression of the serine synthesis enzyme phosphoglycerate dehydrogenase (PHGDH) in some cancers can result from copy number gain of a region on chromosome 1p (Beroukhim et al., 2010; Locasale et al., 2011; Possemato et al., 2011) or a consequence of oncogenic signaling, including NRF2 and ATF4 signaling (DeNicola et al., 2015), or hypoxia responses (Sam”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“A rate-limiting serine biosynthesis enzyme, 3-phosphoglycerate dehydrogenase (PHGDH), is frequently focally amplified in breast cancer and melanoma and is required for the growth of PHGDH-amplified cells in vitro as well as in vivo”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Possemato et al., 2011
In the citing paper
“Amplification of PHGDH has been observed in breast cancer and melanoma (65), and increased PHGDH expression can promote both enhanced serine biosynthesis and the proliferation of cancer cells (65, 66).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [66]
In the citing paper
“the region of chromosome 1p12 encoding PHGDH is amplified in a significant fraction of tumors”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Possemato et al., 2011
In the citing paper
“cell lines derived from these tumors tend to be highly dependent on PHGDH expression”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Possemato et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., Veer, L. V. ‘., Dai, H. A., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,474
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Self-citationDeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,571
Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S., & Sabatini, D. M. (2010) · Cell · doi:10.1016/j.cell.2010.02.024 · Cited by 2,464
Self-citationCancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 2×
“Cancer cells adapt their metabolic processes to drive macromolecular biosynthesis for rapid cell growth and proliferation (1,2).”
Self-citationRhodes, D. R., Sundaram, S. K., Mahavisno, V., Varambally, R., Yu, J., Briggs, B., Barrette, T. R., Anstett, M. J., Kincead-Beal, C., Kulkarni, P., et al. (2007) · Neoplasia · doi:10.1593/neo.07112 · Cited by 2,057
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,804
Self-citationDissecting direct reprogramming through integrative genomic analysis
Mikkelsen, T. S., Hanna, J. H., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B., Jaenisch, R., Lander, E. S., & Meissner, A. (2008) · Nature · doi:10.1038/nature07056 · Cited by 1,515
Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of Embryonic Stem Cells
Marson, A., Levine, S. S., Cole, M. F., Frampton, G. M., Brambrink, T., Johnstone, S. E., Guenther, M. G., Johnston, W. K., Wernig, M., Newman, J. J., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.020 · Cited by 1,405
Cited by
Sorted by citations
Items 401–500 of 1,000
Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia
Haider, S. A., McIntyre, A., van Stiphout, R. G. P. M., Winchester, L. M., Wigfield, S., Harris, A. L., & Buffa, F. M. (2016) · Genome biology · doi:10.1186/s13059-016-0999-8 · Cited by 92
Ocaña, M. C., Martı́nez-Poveda, B., Quesada, A. R., & Medina, M. Á. (2018) · Medicinal Research Reviews · doi:10.1002/med.21511 · Cited by 92
Understanding metabolism with flux analysis: From theory to application
Dai, Z., & Locasale, J. W. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.09.005 · Cited by 92
Yamaguchi, N., Weinberg, E. M., Nguyen, A., Liberti, M. V., Goodarzi, H., Janjigian, Y. Y., Paty, P. B., Saltz, L. B., Kingham, T. P., Loo, J. M., et al. (2019) · eLife · doi:10.7554/elife.52135 · Cited by 91
Metabolic reprogramming in tumors: Contributions of the tumor microenvironment
Lane, A. N., Higashi, R. M., & Fan, T. W.-M. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2019.10.007 · Cited by 91
Hulea, L., Gravel, S., Morita, M., Cargnello, M., Uchenunu, O., Im, Y. K., Lehuédé, C., Ma, E. H., Leibovitch, M., McLaughlan, S., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.001 · Cited by 91
Zhang, Q., Yang, X., Wu, J., Ye, S., Gong, J., Cheng, W. M., Luo, Z., Yu, J., Liu, Y., Zeng, W., et al. (2023) · Cell Discovery · doi:10.1038/s41421-022-00515-x · Cited by 91
Cai, Z., Li, W., Hager, S., Wilson, J. L., Afjehi-Sadat, L., Heiß, E. H., Weichhart, T., Heffeter, P., & Weckwerth, W. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01134-0 · Cited by 91
ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming
Mishra, P., Tang, W., Putluri, V., Dorsey, T. H., Jin, F., Wang, F., Zhu, D., Amable, L., Deng, T., Zhang, S., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93815 · Cited by 91
Reich, S., Nguyen, C. D. L., Has, C., Steltgens, S., Soni, H., Coman, C., Freyberg, M., Bichler, A., Seifert, N., Conrad, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16747-y · Cited by 90
Thewes, V., Simon, R., Hlevnjak, M., Schlotter, M., Schroeter, P., Schmidt, K. V., Wu, Y., Anzeneder, T., Wang, W., Windisch, P. Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.32 · Cited by 90
Metabolomics in noninvasive breast cancer
Zhang, A., Sun, H. J., Qiu, S., & Wang, X. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.05.003 · Cited by 90
Genetically-defined metabolic reprogramming in cancer
Mullen, A. R., & DeBerardinis, R. J. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.06.009 · Cited by 90
Song, Z., Feng, C., Lu, Y., Lin, Y., & Dong, C. (2017) · Gene · doi:10.1016/j.gene.2017.11.014 · Cited by 89
Kampen, K. R., Fancello, L., Girardi, T., Rinaldi, G., Planque, M., Sulima, S. O., Loayza‐Puch, F., Verbelen, B., Vereecke, S., Verbeeck, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10508-2 · Cited by 89
L-serine synthesis via the phosphorylated pathway in humans
Murtas, G., Marcone, G. L., Sacchi, S., & Pollegioni, L. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03574-z · Cited by 89
The Role of Mitochondrial Fat Oxidation in Cancer Cell Proliferation and Survival
Oliveira, M., & Liesa, M. (2020) · Cells · doi:10.3390/cells9122600 · Cited by 89
The alternative activity of nuclear PHGDH contributes to tumour growth under nutrient stress
Ma, C., Zheng, K., Jiang, K., Zhao, Q., Sha, N., Wang, W., Yan, M., Chen, T., Zhao, Y., & Jiang, Y. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00456-x · Cited by 89
Dual roles of PKM2 in cancer metabolism
Wu, S., & Le, H. (2012) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms106 · Cited by 89
Systems Biology, Metabolomics, and Cancer Metabolism
Tomita, M., & Kami, K. (2012) · Science · doi:10.1126/science.1223066 · Cited by 89
Daemen, A., Liu, B., Song, K., Kwong, M., Gao, M., Hong, R., Nannini, M., Peterson, D., Liederer, B. M., de la Cruz, C., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.003 · Cited by 88
PHGDH: a novel therapeutic target in cancer
Lee, C. M., Hwang, Y., Kim, M., Park, Y.-C., Kim, H., & Fang, S. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01268-1 · Cited by 88
Vázquez, A., Markert, E. K., & Oltvai, Z. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025881 · Cited by 88
Oncogene-Driven Metabolic Alterations in Cancer
Min, H., & Lee, H. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.211 · Cited by 88
The evolution of genome-scale models of cancer metabolism
Lewis, N. E., & Abdel-Haleem, A. M. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00237 · Cited by 87
Cai, F., Miao, Y., Liu, C., Wu, T. H., Shen, S.-M., Su, X., & Shi, Y. P. (2017) · Oncology Letters · doi:10.3892/ol.2017.7400 · Cited by 87
LINC00265 promotes colorectal tumorigenesis via ZMIZ2 and USP7-mediated stabilization of β-catenin
Zhu, Y., Gu, L., Lin, X., Cui, K., Liu, C., Lu, B., Zhou, F., Zhao, Q., Shen, H., & Li, Y. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0417-3 · Cited by 87
Nature and Nurture: What Determines Tumor Metabolic Phenotypes?
Mayers, J. R., & Heiden, M. G. V. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0165 · Cited by 86
The emerging role of targeting cancer metabolism for cancer therapy
Farhadi, P., Yarani, R., Dokaneheifard, S., & Mansouri, K. (2020) · Tumor Biology · doi:10.1177/1010428320965284 · Cited by 86
The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming
Phan, L. M., Chou, P., Velázquez-Torres, G., Samudio, I. J., Parreno, K., Huang, Y., Tseng, C., Vu, T., Gully, C., Su, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms8530 · Cited by 86
Nilsson, L. M., Plym Forshell, T. Z., Rimpi, S., Kreutzer, C., Pretsch, W., Bornkamm, G. W., & Nilsson, J. A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002573 · Cited by 85
Serine-dependent redox homeostasis regulates glioblastoma cell survival
Engel, A. L., Lorenz, N. I., Klann, K., Münch, C., Depner, C., Steinbach, J. P., Ronellenfitsch, M. W., & Luger, A.-L. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0794-x · Cited by 85
Increased Expression of PHGDH and Prognostic Significance in Colorectal Cancer
Jia, X.-Q., Zhang, S., Zhu, H., Wang, W., Zhu, J., Wang, X., & Qiang, J. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.03.006 · Cited by 85
Bisphosphoglycerate mutase controls serine pathway flux via 3-phosphoglycerate
Oslund, R., Su, X., Haugbro, M., Kee, J., Esposito, M., David, Y., Wang, B., Ge, E. J., Perlman, D. H., Kang, Y., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2453 · Cited by 85
Geeraerts, S. L., Kampen, K. R., Rinaldi, G., Gupta, P., Planque, M., Louros, N. N., Heylen, E., Cremer, K. D., Brucker, K. D., Vereecke, S., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0480 · Cited by 85
Breast cancer in the era of integrating “Omics” approaches
Rossi, C., Cicalini, I., Cufaro, M. C., Consalvo, A., Upadhyaya, P., Sala, G., Antonucci, I., Boccio, P. D., Stuppia, L., & Laurenzi, V. D. (2022) · Oncogenesis · doi:10.1038/s41389-022-00393-8 · Cited by 85
Lv, M., Gong, Y., Liu, X., Wang, Y., Wu, Q., Chen, J., Min, Q., Zhao, D., Li, X., Chen, D., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01555-9 · Cited by 85
Putluri, N., Maity, S., Kommagani, R., Creighton, C. J., Putluri, V., Chen, F., Nanda, S., Bhowmik, S. K., Terunuma, A., Dorsey, T. H., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.05.007 · Cited by 85
PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma
Yoshino, H., Nohata, N., Miyamoto, K., Yonemori, M., Sakaguchi, T., Sugita, S., Itesako, T., Kofuji, S., Nakagawa, M., Dahiya, R., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1589 · Cited by 88
D-3-Phosphoglycerate Dehydrogenase
Grant, G. A. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00110 · Cited by 84
Li, A. M., Ducker, G. S., Li, Y., Seoane, J. A., Xiao, Y., Melemenidis, S., Zhou, Y., Liu, L., Vanharanta, S., Graves, E. E., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0606 · Cited by 84
Functional Genomics Identifies Metabolic Vulnerabilities in Pancreatic Cancer
Biancur, D. E., Kapner, K. S., Yamamoto, K., Banh, R. S., Neggers, J. E., Sohn, A. S. W., Wu, W., Manguso, R. T., Brown, A., Root, D. E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.018 · Cited by 86
Self-citationLife in the Fast Lane: Mammalian Disease Models in the Genomics Era
Dow, L. E., & Lowe, S. W. (2012) · Cell · doi:10.1016/j.cell.2012.02.023 · Cited by 83
System-wide Clinical Proteomics of Breast Cancer Reveals Global Remodeling of Tissue Homeostasis
Pozniak, Y., Balint‐Lahat, N., Rudolph, J. D., Lindskog, C., Katzir, R., Avivi, C., Pontén, F., Ruppin, E., Barshack, I., & Geiger, T. (2016) · Cell Systems · doi:10.1016/j.cels.2016.02.001 · Cited by 83
Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth
Chen, J., Chung, F., Yang, G., Pu, M., Gao, H., Jiang, W., Yin, H., Capka, V., Kasibhatla, S., Laffitte, B., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1540 · Cited by 82
Interactions between epigenetics and metabolism in cancers
Yun, J., Johnson, J. L., Hanigan, C. L., & Locasale, J. W. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00163 · Cited by 82
Bioinformatics analysis of the serine and glycine pathway in cancer cells
Antonov, A. V., Agostini, M., Morello, M., Minieri, M., Melino, G., & Amelio, I. (2014) · Oncotarget · doi:10.18632/oncotarget.2668 · Cited by 82
Subcellular compartmentalization of NAD+ and its role in cancer: A sereNADe of metabolic melodies
Zhu, Y., Liu, J., Park, J., Rai, P., & Zhai, R. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.002 · Cited by 82
Dissecting the Crosstalk between NRF2 Signaling and Metabolic Processes in Cancer
DeBlasi, J. M., & DeNicola, G. M. (2020) · Cancers · doi:10.3390/cancers12103023 · Cited by 82
Cascales‐Miñana, B., Muñoz‐Bertomeu, J., Flores‐Tornero, M., Anoman, A. D., Pertusa, J., Alaiz, M., Osorio, S., Fernie, A. R., Segura, J., & Ros, R. (2013) · The Plant Cell · doi:10.1105/tpc.113.112359 · Cited by 82
Ishida, C. T., Zhang, Y., Bianchetti, E., Shu, C., Nguyen, T. T. T., Kleiner, G., Sanchez‐Quintero, M. J., Quinzii, C. M., Westhoff, M., Karpel‐Massler, G., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1040 · Cited by 82
Zhang, Z., Cheng, X., Zhao, Y., & Yang, Y. (2020) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-091619-091306 · Cited by 81
Metabolic Signatures of Distinct Endothelial Phenotypes
Dumas, S. J., García‐Caballero, M., & Carmeliet, P. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.05.009 · Cited by 82
An improved model for fragment-based lead generation at AstraZeneca
Fuller, N. O., Spadola, L., Cowen, S. D., Patel, J. S., Schönherr, H., Cao, Q., McKenzie, A. R., Edfeldt, F., Rabow, A., & Goodnow, R. A. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.04.023 · Cited by 81
Woo, C. C., Chen, W. C., Teo, X. Q., Radda, G. K., & Lee, P. T. H. (2016) · Oncotarget · doi:10.18632/oncotarget.10415 · Cited by 81
Self-citationMechanisms of redox metabolism and cancer cell survival during extracellular matrix detachment
Hawk, M. A., & Schafer, Z. T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm117.000260 · Cited by 82
Splicing factor ESRP1 controls ER‐positive breast cancer by altering metabolic pathways
Gökmen‐Polar, Y., Neelamraju, Y., Goswami, C. P., Gu, Y., Gu, X., Nallamothu, G., Vieth, E., Janga, S. C., Ryan, M., & Badve, S. (2019) · EMBO Reports · doi:10.15252/embr.201846078 · Cited by 81
The Omics of Triple-Negative Breast Cancers
Xu, H., Eirew, P. D., Mullaly, S. C., & Aparicio, S. A. J. R. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.207167 · Cited by 80
MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer
Augert, A., Mathsyaraja, H., Ibrahim, A. H., Freie, B. W., Geuenich, M., Cheng, P.-F., Alibeckoff, S. P., Wu, N., Hiatt, J. B., Basom, R., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.04.016 · Cited by 80
Khatib, A., Solaimuthu, B., Yosef, M. B., Rmaileh, A. A., Tanna, M., Oren, G., Frisch, M. S., Axelrod, J. H., Lichtenstein, M., & Shaul, Y. D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010275117 · Cited by 80
Self-citationTherapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer
Dekhne, A. S., Hou, Z., Gangjee, A., & Matherly, L. H. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0423 · Cited by 80
Parallels between embryo and cancer cell metabolism
Smith, D. G., & Sturmey, R. G. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120352 · Cited by 80
Rodrigues, L. M., Uribe‐Lewis, S., Madhu, B., Honess, D. J., Stubbs, M., & Griffiths, J. R. (2017) · Cancer & Metabolism · doi:10.1186/s40170-017-0166-z · Cited by 80
Extracellular Matrix Regulation of Metabolism and Implications for TumorigenesisPreprint
Grassian, A. R., Coloff, J. L., & Brugge, J. S. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010967 · Cited by 80
Serine Biosynthesis Is a Metabolic Vulnerability in FLT3-ITD–Driven Acute Myeloid Leukemia
Bjelosevic, S., Gruber, E., Newbold, A., Shembrey, C., Devlin, J. R., Hogg, S. J., Kats, L. M., Todorovski, I., Fan, Z., Abrehart, T. C., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0738 · Cited by 79
Weinstabl, H., Treu, M., Rinnenthal, J., Zahn, S. K., Ettmayer, P., Bader, G., Dahmann, G., Kessler, D., Rumpel, K., Mischerikow, N., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00718 · Cited by 79
Metabolism during ECM Detachment: Achilles Heel of Cancer Cells?
Mason, J. A., Hagel, K. R., Hawk, M. A., & Schafer, Z. T. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.04.009 · Cited by 78
High Fructose Drives the Serine Synthesis Pathway in Acute Myeloid Leukemic Cells
Jeong, S., Savino, A. M., Chirayil, R., Barin, E., Cheng, Y., Park, S., Schurer, A., Mullarky, E., Cantley, L. C., Kharas, M. G., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.005 · Cited by 78
Metabolic determinants of tumour initiation
Brunner, J. S., & Finley, L. W. S. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00773-5 · Cited by 78
Role of Increased n-acetylaspartate Levels in Cancer
Zand, B., Previs, R. A., Zacharias, N. M., Rupaimoole, R., Mitamura, T., Nagaraja, A. S., Guindani, M., Dalton, H. J., Yang, L., Baddour, J., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv426 · Cited by 78
Bossi, D., Cicalese, A., Dellino, G. I., Luzi, L., Riva, L., D’Alesio, C., Diaferia, G. R., Carugo, A., Cavallaro, E. C., Piccioni, R., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1200 · Cited by 78
Tissue metabolic profiling of human gastric cancer assessed by 1H NMR
Wang, H., Zhang, H., Deng, P., Liu, C., Li, D., Jie, H., Zhang, H., Zhou, Z., & Zhao, Y. (2016) · BMC Cancer · doi:10.1186/s12885-016-2356-4 · Cited by 78
Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures
Graham, N. A., Minasyan, A., Lomova, A., Cass, A. A., Balanis, N. G., Friedman, M., Chan, S. T., Zhao, S. R., Delgado, A., Go, J. L., et al. (2017) · Molecular Systems Biology · doi:10.15252/msb.20167159 · Cited by 78
Cysteine transporter SLC3A1 promotes breast cancer tumorigenesis
Jiang, Y. Z., Cao, Y., Wang, Y., Li, W., Liu, X., Lv, Y., Li, X., & Mi, J. (2017) · Theranostics · doi:10.7150/thno.18005 · Cited by 78
Sun, W. Y., Kim, H. M., Jung, W.-H., & Koo, J. S. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0915-8 · Cited by 77
Mitochondrial One-Carbon Metabolism Maintains Redox Balance during Hypoxia
Martínez‐Reyes, I., & Chandel, N. S. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1228 · Cited by 77
PYCR1 and PYCR2 Interact and Collaborate with RRM2B to Protect Cells from Overt Oxidative Stress
Kuo, M.-L., Lee, M. B.-E., Tang, M., den Besten, W., Hu, S., Sweredoski, M. J., Hess, S. Y., Chou, C., Changou, C. A., Su, M., et al. (2016) · Scientific Reports · doi:10.1038/srep18846 · Cited by 77
Links between cancer metabolism and cisplatin resistance
Cocetta, V., Ragazzi, E., & Montopoli, M. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.01.005 · Cited by 77
Severson, T., Wolf, D. M., Yau, C. S. F., Peeters, J. K., Wehkam, D., Schouten, P. C., Chin, S., Majewski, I. J., Michaut, M., Bosma, A. R., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0861-2 · Cited by 77
The Regulation of NRF2 by Nutrient-Responsive Signaling and Its Role in Anabolic Cancer Metabolism
Lee, S. B., Sellers, B. N., & DeNicola, G. M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7356 · Cited by 78
Signaling Pathways Regulating Redox Balance in Cancer Metabolism
Santis, M. C. D., Porporato, P. E., Martini, M., & Morandi, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00126 · Cited by 77
Dietary restriction of amino acids for Cancer therapy
Kang, J. (2020) · Nutrition & Metabolism · doi:10.1186/s12986-020-00439-x · Cited by 77
Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism
Cacace, A., Sboarina, M., Vazeille, T., & Sonveaux, P. (2017) · Oncogene · doi:10.1038/onc.2016.364 · Cited by 76
Liu, G., Hou, G., Li, L., Li, Y., Zhou, W., & Liu, L. (2016) · Oncotarget · doi:10.18632/oncotarget.8927 · Cited by 76
Ayuso, M., Fernández, A., Núñez, Y., Benítez, R., Isabel, B., Fernández, A. I., Rey, A. I., Gonzalez‐Bulnes, A., Medrano, J. F. F., Cánovas, Á., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167858 · Cited by 76
Selenium reduction of ubiquinone via SQOR suppresses ferroptosis
Lee, N., Park, S. J., Lange, M., Tseyang, T., Doshi, M. B., Kim, T. Y., Song, Y., Kim, D. I., Greer, P. L., Olzmann, J. A., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-00974-4 · Cited by 76
Self-citationCancer Metabolism: A Modeling Perspective
Ghaffari, P., Mardinoğlu, A., & Nielsen, J. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00382 · Cited by 76
Serine Synthesis Helps Hypoxic Cancer Stem Cells Regulate Redox
Samanta, D., & Semenza, G. L. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1730 · Cited by 76
Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia
Zhou, J., Bi, C., Ching, Y. Q., Chooi, J.-Y., Lu, X., Quah, J. Y., Toh, S. H. M., Chan, Z.-L., Tan, T. Z., Chong, P. S. Y., et al. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0507-y · Cited by 76
High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer
Zhu, J., Ma, J., Wang, X., Ma, T., Zhang, S., Wang, W., Zhou, X., & Shi, J. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.08.003 · Cited by 75
Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry
Mal, M., Koh, P. K., Cheah, P. Y., & Chan, E. C. Y. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-5870-5 · Cited by 75
Pinweha, P., Rattanapornsompong, K., Charoensawan, V., & Jitrapakdee, S. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.05.005 · Cited by 75
Xiu, Y., & Field, M. S. (2020) · Current Developments in Nutrition · doi:10.1093/cdn/nzaa153 · Cited by 75
Hasan, M. N., Capuk, O., Patel, S. M., & Sun, D. (2022) · Cancers · doi:10.3390/cancers14143331 · Cited by 75
Sources and Sinks of Serine in Nutrition, Health, and Disease
Handzlik, M. K., & Metallo, C. M. (2023) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061021-022648 · Cited by 75
Metabolic Mechanisms of Epigenetic Regulation
Meier, J. L. (2013) · ACS Chemical Biology · doi:10.1021/cb400689r · Cited by 75
The NAD+ Salvage Pathway Supports PHGDH-Driven Serine Biosynthesis
Murphy, J. P., Giacomantonio, M., Paulo, J. A., Everley, R. A., Kennedy, B. E., Pathak, G. P., Clements, D. R., Kim, Y., Dai, C., Sharif, T., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.086 · Cited by 75
Sulfur metabolism and its contribution to malignancy
Ward, N. P., & DeNicola, G. M. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.05.001 · Cited by 74
Ye, G., Zhu, B., Yao, Z., Yin, P., Lu, X., Kong, H., Fan, F., Jiao, B., & Xu, G. (2012) · Journal of Proteome Research · doi:10.1021/pr300502v · Cited by 73
Jiang, X., Sun, Q., Li, H., Li, K., & Ren, X. (2013) · International Journal of Cancer · doi:10.1002/ijc.28637 · Cited by 73
Metadata
- Authors
- Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., Chen, W. W., Barrett, F. G., Stransky, N., Tsun, Z.-Y., Cowley, G. S., Barretina, J., Kalaany, N. Y., Hsu, P. P., Ottina, K., Chan, A. M., Yuan, B., Garraway, L. A., Root, D. E., Mino-Kenudson, M., Brachtel, E. F., Driggers, E. M., & Sabatini, D. M.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Agios Pharmaceuticals (United States) (US)
- Broad Institute (US)
- Harvard University (US)
- Corresponding author
- Sabatini, David M.
- ORCID
- Possemato, Richard
- Shaul, Yoav D.
- Pacold, Michael E.
- Kim, Dohoon
- Birsoy, Kıvanç
- Sethumadhavan, Shalini
- Jang, Hyun G.
- Jha, Abhishek K.
- Chen, Walter W.
- Barrett, Francesca G.
- Stransky, Nicolas
- Cowley, Glenn S.
- Barretina, Jordi
- Kalaany, Nada Y.
- Hsu, Peggy P.
- Yuan, Bingbing
- Garraway, Levi A.
- Root, David E.
- Mino-Kenudson, Mari
- Brachtel, Elena F.
- Sabatini, David M.
- Venue
- Nature
- Published
- 2011-08
- Volume
- 476
- Issue
- 7360
- Pages
- 346-350
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3353325
- OpenAlex
- W2022899908
- Cited by
- 1,683
- References
- 27
- Citations by year
- 2026: 72 · 2025: 111 · 2024: 120 · 2023: 116 · 2022: 138 · 2021: 167 · 2020: 137 · 2019: 126 · 2018: 93 · 2017: 97 · 2016: 125 · 2015: 93 · 2014: 109 · 2013: 72 · 2012: 87
- FWCI
- 31.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- RePEc: Research Papers in Economics (submittedVersion)
- PMC
- Funders
- Howard Hughes Medical Institute
- W. M. Keck Foundation
- Alexander and Margaret Stewart Trust
- Life Sciences Research Foundation
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- National Institutes of Health
- National Cancer Institute (CA103866, R01CA103866, R01CA129105)
- National Institute of General Medical Sciences (T32GM007753)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- PHGDH, breast cancer, cancer metabolism, breast cancer xenografts, estrogen receptor-negative breast cancer, alpha-ketoglutarate, glutamine metabolism, TCA cycle, anaplerosis, tumor metabolic reprogramming, anticancer drug targets, cell proliferation
- MeSH terms
- Animals, Breast Neoplasms, Citric Acid Cycle, Humans, Ketoglutaric Acids, Melanoma, Neoplasm Transplantation, Serine, Biomarkers, Tumor, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Glutamic Acid, Genomics, RNA Interference, Cell Line, Tumor, Cell Proliferation, Phosphoglycerate Dehydrogenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
